{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:30:40Z","timestamp":1793323840085,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005362","name":"Universita degli Studi di Bari Aldo Moro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bmc.2026.118760","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:39:12Z","timestamp":1785220752000},"page":"118760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Lead optimization of rivastigmine-like hybrids: Impact of nitro group and halogen substitution on multi-target anti-Alzheimer's activity"],"prefix":"10.1016","volume":"141","author":[{"given":"Rosalba","family":"Leuci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Paparella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Simic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Carrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Tortorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Loiodice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Laghezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Am\u00e9lia","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Wackerlig-Damle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Piemontese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118760_bb0005","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/17460441.2018.1457645","article-title":"Have there been improvements in Alzheimer\u2019s disease drug discovery over the past 5 years?","volume":"13","author":"Cacabelos","year":"2018","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmc.2026.118760_bb0010","article-title":"Alzheimer\u2019s disease drug development pipeline: 2024","volume":"10","author":"Cummings","year":"2024","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.bmc.2026.118760_bb0015","doi-asserted-by":"crossref","unstructured":"Molkov, Y.I.; Zaretskaia, M.V.; Zaretsky, D.V. Towards the integrative theory of Alzheimer's disease: linking molecular mechanisms of neurotoxicity, beta-amyloid biomarkers, and the diagnosis. Curr Alzheimer Res 20, 440\u2013452, doi:https:\/\/doi.org\/10.2174\/1567205020666230821141745.","DOI":"10.2174\/1567205020666230821141745"},{"key":"10.1016\/j.bmc.2026.118760_bb0020","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.bmc.2026.118760_bb0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer\u2019s disease: targeting the cholinergic system","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.bmc.2026.118760_bb0030","series-title":"Handbook of Clinical Neurology","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/B978-0-443-19088-9.00005-6","article-title":"The involvement of the cholinergic system in Alzheimer disease","volume":"211","year":"2025"},{"key":"10.1016\/j.bmc.2026.118760_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgeb.2025.100530","article-title":"Targeting cholinergic dysfunction in Alzheimer\u2019s disease: development of next-generation galantamine derivatives","volume":"23","author":"Keshavarz","year":"2025","journal-title":"Journal of Genetic Engineering and Biotechnology"},{"key":"10.1016\/j.bmc.2026.118760_bb0040","article-title":"A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer\u2019s disease","volume":"15","author":"Nordberg","year":"2013","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.bmc.2026.118760_bb0045","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-\u03b2 protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.bmc.2026.118760_bb0050","doi-asserted-by":"crossref","first-page":"11172","DOI":"10.1073\/pnas.0603838103","article-title":"Alzheimer\u2019s disease \u03b2-amyloid peptides are released in association with exosomes","volume":"103","author":"Rajendran","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2026.118760_bb0055","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1755-5949.2010.00177.x","article-title":"The role of tau in Alzheimer\u2019s disease and related disorders","volume":"17","author":"Medeiros","year":"2011","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"10.1016\/j.bmc.2026.118760_bb0060","article-title":"Metals in Alzheimer\u2019s disease","volume":"11","author":"Leko","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bmc.2026.118760_bb0065","article-title":"Cu(I) is a game changer in the arrest of cu(a\u03b2)-induced ROS production in the presence of competing Zn(II) ions","volume":"32","author":"Drommi","year":"2026","journal-title":"Chem Eur J"},{"key":"10.1016\/j.bmc.2026.118760_bb0070","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease","volume":"57","author":"T\u00f6nnies","year":"2017","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.bmc.2026.118760_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2017.00300","article-title":"Serum copper, zinc, and iron levels in patients with Alzheimer\u2019s disease: a meta-analysis of case-control studies","volume":"9","author":"Li","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.bmc.2026.118760_bb0080","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bmc.2026.118760_bb0085","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-0039-1678581","article-title":"Current and future treatments in Alzheimer\u2019s disease","volume":"39","author":"Atri","year":"2019","journal-title":"Semin Neurol"},{"key":"10.1016\/j.bmc.2026.118760_bb0090","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2147\/CIA.S129145","article-title":"Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson\u2019s disease dementia","volume":"12","author":"Kandiah","year":"2017","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.bmc.2026.118760_bb0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7861\/clinmedicine.16-3-247","article-title":"Drug treatments in Alzheimer\u2019s disease","volume":"16","author":"Briggs","year":"2016","journal-title":"Clinical Medicine"},{"key":"10.1016\/j.bmc.2026.118760_bb0100","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neuroscience.2025.10.011","article-title":"Anti-amyloid monoclonal antibody therapies in Alzheimer\u2019s disease \u2013 a scoping review","volume":"589","author":"Elamin","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.bmc.2026.118760_bb0105","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4155\/fmc-2016-0003","article-title":"Multitarget strategies in Alzheimer\u2019s disease: benefits and challenges on the road to therapeutics","volume":"8","author":"Rosini","year":"2016","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmc.2026.118760_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.837649","article-title":"Multi-targets: an unconventional drug development strategy for Alzheimer\u2019s disease","volume":"14","author":"Gong","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.bmc.2026.118760_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107152","article-title":"A comprehensive review of multi-target directed ligands in the treatment of Alzheimer\u2019s disease","volume":"144","author":"Pathak","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118760_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107895","article-title":"Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer\u2019s drug candidates","volume":"153","author":"Leuci","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118760_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114358","article-title":"Structure-based Design of Novel Donepezil-like Hybrids for a multi-target approach to the therapy of Alzheimer\u2019s disease","volume":"237","author":"Brunetti","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118760_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/M1863","article-title":"3-((2-(4-Chloro-5-ethoxy-2-nitrophenoxy)acetamido)methyl)phenyl-dimethylcarbamate","volume":"2024","author":"Leuci","year":"2024","journal-title":"Molbank"},{"key":"10.1016\/j.bmc.2026.118760_bb0135","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ansa.202200004","article-title":"Biomimetic chromatography\u2014a novel application of the chromatographic principles","volume":"3","author":"Valko","year":"2022","journal-title":"Analytical Science Advances"},{"key":"10.1016\/j.bmc.2026.118760_bb0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bcp.2013.09.007","article-title":"Pharmacokinetics","volume":"87","author":"Fan","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2026.118760_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nucmedbio.2017.03.003","article-title":"LogP, a yesterday\u2019s value?","volume":"50","author":"Vraka","year":"2017","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.bmc.2026.118760_bb0150","doi-asserted-by":"crossref","first-page":"751","DOI":"10.4103\/NRR.NRR-D-24-00140","article-title":"Role of copper chelating agents: between old applications and new perspectives in neuroscience","volume":"20","author":"Leuci","year":"2025","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.bmc.2026.118760_bb0155","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.2174\/0929867328666210218183032","article-title":"Recent multi-target approaches on the development of anti- Alzheimer\u2019s agents integrating metal chelation activity","volume":"28","author":"Chaves","year":"2021","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2026.118760_bb0160","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.jmb.2019.01.018","article-title":"Metal toxicity links to Alzheimer\u2019s disease and neuroinflammation","volume":"431","author":"Huat","year":"2019","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmc.2026.118760_bb0165","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/0039-9140(96)01958-3","article-title":"Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs","volume":"43","author":"Gans","year":"1996","journal-title":"Talanta"},{"key":"10.1016\/j.bmc.2026.118760_bb0170","series-title":"PSEQUAD","author":"Z\u00e9k\u00e1ny","year":"2001"},{"key":"10.1016\/j.bmc.2026.118760_bb0175","series-title":"Critical Stability Constants","author":"Smith","year":"1975"},{"key":"10.1016\/j.bmc.2026.118760_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098312","article-title":"Rivastigmine\u2013benzimidazole hybrids as promising multitarget metal-modulating compounds for potential treatment of neurodegenerative diseases","volume":"24","author":"Vicente-Zurdo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118760_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2024.112734","article-title":"Exploiting the potential of rivastigmine-melatonin derivatives as multitarget metal-modulating drugs for neurodegenerative diseases","volume":"262","author":"Dias","year":"2025","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.bmc.2026.118760_bb0190","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1021\/ar50137a004","article-title":"Coordination chemistry and microbial Iron transport","volume":"12","author":"Raymond","year":"1979","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.bmc.2026.118760_bb0195","doi-asserted-by":"crossref","first-page":"11998","DOI":"10.1002\/anie.201304157","article-title":"Method of continuous variations: applications of job plots to the study of molecular associations in organometallic chemistry","volume":"52","author":"Renny","year":"2013","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmc.2026.118760_bb0200","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2026.118760_bb0205","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0891-5849(98)00315-3","article-title":"Antioxidant activity applying an improved ABTS radical cation decolorization assay","volume":"26","author":"Re","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bmc.2026.118760_bb0210","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1021\/ed042p375","article-title":"Potentiometric titrations using gran plots: a textbook omission","volume":"42","author":"Rossotti","year":"1965","journal-title":"J Chem Educ"},{"key":"10.1016\/j.bmc.2026.118760_bb0215","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0021-9673(02)00064-X","article-title":"Method for measuring the logarithm of the octanol-water partition coefficient by using short octadecyl-poly(vinyl alcohol) high-performance liquid chromatography columns","volume":"952","author":"Donovan","year":"2002","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.bmc.2026.118760_bb0220","doi-asserted-by":"crossref","first-page":"38581","DOI":"10.1021\/acsomega.6c00701","article-title":"From the gut to the brain: modeling intestinal absorption and assessing blood\u2013brain-barrier permeability of small-molecule drugs by IAM chromatography","volume":"11","author":"Simi\u0107","year":"2026","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmc.2026.118760_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.06.011","article-title":"A new crystal form of human acetylcholinesterase for exploratory room-temperature crystallography studies","volume":"309","author":"Gerlits","year":"2019","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmc.2026.118760_bb0230","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1021\/acs.jmedchem.1c00048","article-title":"Sustainable drug discovery of multi-target-directed ligands for Alzheimer\u2019s disease","volume":"64","author":"Rossi","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118760_bb0235","author":"Schr\u00f6dinger LLC"},{"key":"10.1016\/j.bmc.2026.118760_bb0240","author":"QUACPAC"},{"key":"10.1016\/j.bmc.2026.118760_bb0245","first-page":"33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"Aust J Chem"},{"key":"10.1016\/j.bmc.2026.118760_bb0250","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2026.118760_bb0255","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10822-019-00240-w","article-title":"Comparison of affinity ranking using AutoDock-GPU and MM-GBSA scores for BACE-1 inhibitors in the D3R grand challenge 4","volume":"33","author":"El Khoury","year":"2019","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.bmc.2026.118760_bb0260","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1021\/jm2005145","article-title":"A force field with discrete displaceable waters and Desolvation entropy for hydrated ligand docking","volume":"55","author":"Forli","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118760_bb0265","author":"OpenEye Scientific Software"},{"key":"10.1016\/j.bmc.2026.118760_bb0270","series-title":"Proceedings of the Proceedings of the 2006 ACM\/IEEE conference on supercomputing - SC \u201806","first-page":"84","article-title":"Molecular Dynamics---Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters","author":"Bowers","year":"2006"},{"key":"10.1016\/j.bmc.2026.118760_bb0275","author":"Schr\u00f6dinger LLC"},{"key":"10.1016\/j.bmc.2026.118760_bb0280","series-title":"The PyMOL Molecular Graphics System, Version 3.1\u20130","author":"Schr\u00f6dinger, LLC","year":"2026"},{"key":"10.1016\/j.bmc.2026.118760_bb0285","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.bpj.2015.08.015","article-title":"MDTraj: a modern open library for the analysis of molecular dynamics trajectories","volume":"109","author":"McGibbon","year":"2015","journal-title":"Biophys J"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:22:50Z","timestamp":1786015370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626002166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":57,"alternative-id":["S0968089626002166"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118760","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lead optimization of rivastigmine-like hybrids: Impact of nitro group and halogen substitution on multi-target anti-Alzheimer's activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118760","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"118760"}}